Merlaycin

Merlaycin is a direct-to-consumer skin-care label that concentrates on clinical-strength melasma, hyper-pigmentation and sun-damage solutions. The streamlined assortment is built around three hydroquinone-free “Tyrosinase Control” serums ($38-$52), a gentle enzyme cleanser ($18) and broad-spectrum mineral SPF ($24), placing the brand in the accessible-to-mid range. Sales are handled exclusively through merlaycin.com with global shipping and a 30-day refund policy. The formulas stand out by pairing tranexamic acid, alpha-arbutin and resveratrol at pH 4.2-4.8—levels the site documents with third-party lab data for 28-day spot-lightening efficacy. All products are fragrance-free, packaged in opaque airless pumps, and manufactured in small U.S. FDA-registered batches that list exact active percentages, a transparency move rare at this price tier. Core buyers are 25-45-year-old women who have tried prescription bleaches, experienced irritation, and want visible fading without cyclical hydroquinone breaks. The brand speaks to ingredient realists who follow dermatology journals, value documented pigment-inhibition metrics, and prefer minimalist routines that fit under makeup and within clean-beauty lifestyles. Merlaycin competes against mass-market “dark-spot correctors” sold in drugstores and the entry-level arm of dermatologist-founded cosmeceutical lines. It undercuts premium clinic brands by eliminating retail mark-ups, yet offers comparable actives at higher concentrations than big-box serums, staking out a niche of evidence-based pigment care priced for routine, long-term use.